Dr. Robert Scharpf and Dr. Victor Velculescu discuss using DNA fragmentation profiles to analyze cell-free DNA and detect cancer from liquid biopsies. The machine learning-based method they developed could serve as a low-cost screening tool for a wide range of cancers.
from CCG Updates and Insights https://ift.tt/2qhw1KW
from CCG Updates and Insights https://ift.tt/2qhw1KW